Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Endometrial Neoplasms × avelumab × Clear all

Phase

Status

Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sarcoma 1 Penile Neoplasms 1 PD-L1 Positive Mutation Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 Hemangiosarcoma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Paclitaxel 6 Carboplatin 6 Radiotherapy 5 olaparib 4 Cisplatin 4 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Sentinel Lymph Node Biopsy 3 Metformin 3 pembrolizumab 2 lenvatinib 2 durvalumab 2 dostarlimab 2 anlotinib 2 Reverse Transcriptase Polymerase Chain Reaction 2 Progesterone 2 Magnetic Resonance Spectroscopy 2 Injections 2 Hematologic Tests 2 Genetic Testing 2 Docetaxel 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2 vistusertib 1 serabelisib 1 pazopanib 1 palbociclib 1 onapristone 1 niraparib 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03503786 2023-11-13

MITO END-3

National Cancer Institute, Naples

Phase 2 Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡